Literature DB >> 33529126

Human Vaccines & Immunotherapeutics: news.

.   

Abstract

Entities:  

Year:  2021        PMID： 33529126      PMCID： PMC7872025          DOI： 10.1080/21645515.2021.1872243

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  2 in total

1.  Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials.

Authors:  Brian J Ward; Alexander Makarkov; Annie Séguin; Stéphane Pillet; Sonia Trépanier; Jiwanjeet Dhaliwall; Michael D Libman; Timo Vesikari; Nathalie Landry
Journal:  Lancet       Date:  2020-10-13       Impact factor: 79.321

2.  Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.

Authors:  Pravin T P Kaumaya; Linlin Guo; Jay Overholser; Manuel L Penichet; Tanios Bekaii-Saab
Journal:  Oncoimmunology       Date:  2020-10-01       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.